As of 2025-07-19, the Relative Valuation of Altimmune Inc (ALT) is (14.74) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.08 USD, the upside of Altimmune Inc based on Relative Valuation is -461.3%.
The range of the Relative Valuation is (10.97) - (20.56) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.6x - 18.5x | 13.0x |
| Forward P/E multiples | 9.9x - 21.0x | 13.5x |
| Fair Price | (10.97) - (20.56) | (14.74) |
| Upside | -368.9% - -603.9% | -461.3% |
| Date | P/E |
| 2025-07-17 | -3.64 |
| 2025-07-16 | -3.76 |
| 2025-07-15 | -3.76 |
| 2025-07-14 | -3.83 |
| 2025-07-11 | -3.72 |
| 2025-07-10 | -3.95 |
| 2025-07-09 | -4.26 |
| 2025-07-08 | -4.12 |
| 2025-07-07 | -3.98 |
| 2025-07-03 | -4.28 |
| 2025-07-02 | -4.40 |
| 2025-07-01 | -3.80 |
| 2025-06-30 | -3.48 |
| 2025-06-27 | -3.15 |
| 2025-06-26 | -3.24 |
| 2025-06-25 | -6.93 |
| 2025-06-24 | -6.46 |
| 2025-06-23 | -6.28 |
| 2025-06-20 | -6.32 |
| 2025-06-18 | -6.09 |
| 2025-06-17 | -6.19 |
| 2025-06-16 | -6.17 |
| 2025-06-13 | -6.22 |
| 2025-06-12 | -6.43 |
| 2025-06-11 | -5.88 |
| 2025-06-10 | -6.06 |
| 2025-06-09 | -5.35 |
| 2025-06-06 | -5.05 |
| 2025-06-05 | -4.91 |
| 2025-06-04 | -4.93 |
| 2025-06-03 | -4.87 |
| 2025-06-02 | -4.76 |
| 2025-05-30 | -4.88 |
| 2025-05-29 | -5.04 |
| 2025-05-28 | -4.93 |
| 2025-05-27 | -4.95 |
| 2025-05-23 | -5.13 |
| 2025-05-22 | -5.19 |
| 2025-05-21 | -5.02 |
| 2025-05-20 | -5.26 |
| 2025-05-19 | -4.94 |
| 2025-05-16 | -5.02 |
| 2025-05-15 | -5.20 |
| 2025-05-14 | -5.12 |
| 2025-05-13 | -5.18 |
| 2025-05-12 | -5.40 |
| 2025-05-09 | -5.02 |
| 2025-05-08 | -5.21 |
| 2025-05-07 | -4.82 |
| 2025-05-06 | -4.52 |